CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
2.270
-0.010 (-0.44%)
May 13, 2025, 4:00 PM - Market closed

CytoMed Therapeutics Cash Flow Statement

Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-2.52-4.13-3.13-2.05-1.94
Upgrade
Depreciation & Amortization
0.330.380.390.330.29
Upgrade
Other Amortization
00-0-
Upgrade
Loss (Gain) From Sale of Assets
---0--
Upgrade
Asset Writedown & Restructuring Costs
--0--
Upgrade
Loss (Gain) on Equity Investments
-0.010.030.030.21-
Upgrade
Other Operating Activities
-0.450.081.20.170.68
Upgrade
Change in Accounts Receivable
-0.08-0.01-0.15-0.43-0.16
Upgrade
Change in Accounts Payable
-0.080.110.270.060.28
Upgrade
Change in Unearned Revenue
0.10-0.01--
Upgrade
Operating Cash Flow
-2.71-3.53-1.4-1.71-0.85
Upgrade
Capital Expenditures
-1.4-0.06-0.47-0.58-0.24
Upgrade
Sale of Property, Plant & Equipment
--0--
Upgrade
Divestitures
0.16----
Upgrade
Sale (Purchase) of Intangibles
-0.09----0.02
Upgrade
Investment in Securities
2.5-2.77--0.24-0.25
Upgrade
Other Investing Activities
0.470.1---
Upgrade
Investing Cash Flow
1.13-2.73-0.47-0.82-0.51
Upgrade
Short-Term Debt Issued
--0.30.351.5
Upgrade
Total Debt Issued
--0.30.351.5
Upgrade
Short-Term Debt Repaid
--0.3-0.35--
Upgrade
Long-Term Debt Repaid
-0.04-0.04-0.08-0.06-0.01
Upgrade
Total Debt Repaid
-0.04-0.34-0.43-0.06-0.01
Upgrade
Net Debt Issued (Repaid)
-0.04-0.34-0.130.291.49
Upgrade
Issuance of Common Stock
-11.311.2240.5
Upgrade
Other Financing Activities
-0.02-0.05-0.13-0.12-0.11
Upgrade
Financing Cash Flow
-0.0610.920.974.171.88
Upgrade
Foreign Exchange Rate Adjustments
0.12-0.01-0.03-0.01-0.01
Upgrade
Net Cash Flow
-1.534.64-0.931.630.51
Upgrade
Free Cash Flow
-4.11-3.59-1.87-2.3-1.09
Upgrade
Free Cash Flow Margin
-816.52%-706.96%-514.47%-2016.27%-1839.93%
Upgrade
Free Cash Flow Per Share
-0.36-0.34-0.24-0.33-0.19
Upgrade
Cash Interest Paid
0.020.050.130.120.11
Upgrade
Cash Income Tax Paid
-0---
Upgrade
Levered Free Cash Flow
-3.17-2.04-1.29-1.75-1.28
Upgrade
Unlevered Free Cash Flow
-3.16-2.01-1.21-1.68-1.22
Upgrade
Change in Net Working Capital
0.04-0.07-0.030.340.42
Upgrade
Updated Sep 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q